Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis
Journal of the European Academy of Dermatology and Venereology · 2025-03 · 39 (S1) · 3-5
DOI: 10.1111/jdv.20554 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 24.02.2025. Verfasst von Diamant Thaçi. Beteiligte Einrichtung: Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Johnson and Johnson Innovative Medicine, Johnson & Johnson Innovative Medicine.
Abstract (Originalsprache)
Procedures followed were in accordance with the ethical standards of
Autor:innen und Institutionen
- Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Förderung
- Johnson and Johnson Innovative Medicine
- Johnson & Johnson Innovative Medicine
Zitieren
APA
Thaçi, D. (2025). Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology, 39(S1), 3-5. https://doi.org/10.1111/jdv.20554
Vancouver
Thaçi D. Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology. 2025;39(S1):3-5. doi:10.1111/jdv.20554
BibTeX
@article{Thai2025,
author = {Thaçi, Diamant},
title = {Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {S1},
pages = {3--5},
doi = {10.1111/jdv.20554}
}
EUVIMED